Herold Advisors, Inc. Merck & Co., Inc. Transaction History

Herold Advisors, Inc.

$423 Million
Q2 2024

A detailed history of Herold Advisors, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Herold Advisors, Inc. holds 37,209 shares of MRK stock, worth $4.39 Million. This represents 1.09% of its overall portfolio holdings.

Number of Shares

37,209

Previous 37,165 0.12%

Holding current value

$4.39 Million

Previous $4.9 Million 6.06%

% of portfolio

1.09%

Previous 1.21%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 24, 2024	BUY	$123.8 - $132.96 $5,447 - $5,850	44 Added 0.12%	37,209 $4.61 Million
Q1 2024 May 10, 2024	SELL	$113.24 - $131.95 $71,001 - $82,732	-627 Reduced 1.66%	37,165 $4.9 Million
Q4 2023 Feb 02, 2024	BUY	$100.18 - $109.02 $85,553 - $93,103	854 Added 2.31%	37,792 $4.12 Million
Q3 2023 Nov 08, 2023	BUY	$102.95 - $114.33 $59,299 - $65,854	576 Added 1.58%	36,938 $3.8 Million
Q2 2023 Jul 14, 2023	BUY	$108.61 - $118.38 $164,326 - $179,108	1,513 Added 4.34%	36,362 $4.2 Million
Q1 2023 Apr 19, 2023	BUY	$102.94 - $114.86 $369,039 - $411,773	3,585 Added 11.47%	34,849 $3.71 Million
Q4 2022 Feb 14, 2023	BUY	$87.44 - $112.11 $218,162 - $279,714	2,495 Added 8.67%	31,264 $3.47 Million
Q3 2022 Nov 08, 2022	BUY	$84.53 - $94.96 $333,386 - $374,522	3,944 Added 15.89%	28,769 $2.48 Million
Q2 2022 Jul 15, 2022	BUY	$83.49 - $94.64 $15,111 - $17,129	181 Added 0.73%	24,825 $2.26 Million
Q1 2022 May 09, 2022	BUY	$73.51 - $82.4 $260,886 - $292,437	3,549 Added 16.82%	24,644 $2.02 Million
Q4 2021 Jan 20, 2022	BUY	$72.28 - $90.54 $67,003 - $83,930	927 Added 4.6%	21,095 $1.62 Million
Q3 2021 Nov 03, 2021	BUY	$71.68 - $78.83 $1.45 Million - $1.59 Million	20,168 New	20,168 $1.51 Million

Others Institutions Holding MRK

# of Institutions

3,825

Shares Held

1.91B

Call Options Held

13.4M

Put Options Held

10.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $299B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Herold Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Herold Advisors, Inc. with notifications on news.

Account

Herold Advisors, Inc. Merck & Co., Inc. Transaction History